Company Analysis

enVVeno Medical Corporation (NVNO)

Nasdaq: NVNO · Surgical & Medical Instruments & Apparatus · Irvine, CA · filing with the SEC since 2015
Grade3.6
◀ Past 1.8● Present 4.4▶ Future 4.2
3 est.
The companyfiscal 2019, as filed
Revenue$31,243-83.3%
Net income-$7.6M+41.5%
Earnings per sharen/a
Operating cash flow-$5.9M+7.2%
Cash$1.3M-52.3%
Debtn/a
Shareholders’ equity$989,940-51.4%
Shares, dilutedn/a
Return on equity-71.8%
The recordfrom its filings
Filings in 202628
Newest filingNov 10 · SCHEDULE 13G/A
Annual reportMar 26, 2026
Quarterly reportOct 29, 2026
Next report due10-K by Mar 31
Insider sales, 12 months$0.00
Insider buys, 12 months$0.00
Patents granted17
Filer categoryNon-accelerated filer<br>Smaller reporting company
Trailing twelve months to Sep 2026Net income -$15.6MCash from operations -$13.4Mthe four newest filed quarters added
Left: the newest annual report, with the change on the year before. Right: counted from the company's own filings with the SEC.
Revenue and net income by fiscal yearRevenueNet income
171819202122232425
As filed, in USD. Nothing here is a forecast.

News

Oct 29, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form DEFA14A
Extra proxy material
Open the filing on sec.gov
Oct 29, 2026 · SEC EDGAR · Form DEF 14A
Proxy statement
Open the filing on sec.gov
Sep 14, 2026 · SEC EDGAR · Form 4
Insider trade report
Open the filing on sec.gov
Aug 21, 2026 · SEC EDGAR · Form S-3
Shelf registration
Open the filing on sec.gov
Jul 30, 2026 · SEC EDGAR · Form 10-Q
Quarterly report
Open the filing on sec.gov
An outside story is shown by its headline, its source and its link only. The SI reads the page when you ask it to break one down.
SI Assistanton NVNO · research, not advice